Código QR

Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing

The recent therapeutic success of immune checkpoint inhibitors in the treatment of advanced melanoma highlights the potential of cancer immunotherapy. Oncolytic virus-based therapies may further improve the outcome of these cancer patients. A human ex vivo melanoma model was used to investigate the...

Descrición completa

Gardado en:
Principais autores: Katrin Goepfert, Christiane Dinsart, Jean Rommelaere, Friedrich Foerster, Markus Moehler
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Oncology
Assuntos:
melanoma
immune cells
H-1PV
nivolumab
ipilimumab
immunotherapy
Acceso en liña:https://www.frontiersin.org/article/10.3389/fonc.2019.00425/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares